Roger Md Medel - Jan 5, 2022 Form 4 Insider Report for MEDNAX, INC. (MD)

Role: Director
Signature: /s/ Dominic J. Andreano, Attorney-in-Fact
Stock symbol: MD
Transactions as of: Jan 5, 2022
Transactions value $: -$346,561
Form type: 4
Date filed: 1/7/2022, 03:28 PM
Previous filing: Jan 4, 2022
Next filing: Jan 11, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MD	Common Stock	Sale	-$347K	-12.6K	-1.48%	$27.42	839K	Jan 5, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Sales made pursuant to reporting person's 10b5-1 trading plan adopted August 25, 2021.
F2	The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.99 to $27.63 for a weighted average sales price of $27.42. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Sales made pursuant to reporting person's 10b5-1 trading plan adopted August 25, 2021.

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.99 to $27.63 for a weighted average sales price of $27.42. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.